Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Implantable cardioverter-defibrillator (ICD) therapy has been shown to improve survival in patients with various heart conditions who are at high risk for ventricular arrhythmias. Whether benefit occurs in patients early after myocardial infarction is unknown. METHODS: We conducted the Defibrillator in Acute Myocardial Infarction Trial, a randomized, open-label comparison of ICD therapy (in 332 patients) and no ICD therapy (in 342 patients) 6 to 40 days after a myocardial infarction. We enrolled patients who had reduced left ventricular function (left ventricular ejection fraction, 0.35 or less) and impaired cardiac autonomic function (manifested as depressed heart-rate variability or an elevated average 24-hour heart rate on Holter monitoring). The primary outcome was mortality from any cause. Death from arrhythmia was a predefined secondary outcome. RESULTS: During a mean (+/-SD) follow-up period of 30+/-13 months, there was no difference in overall mortality between the two treatment groups: of the 120 patients who died, 62 were in the ICD group and 58 in the control group (hazard ratio for death in the ICD group, 1.08; 95 percent confidence interval, 0.76 to 1.55; P=0.66). There were 12 deaths due to arrhythmia in the ICD group, as compared with 29 in the control group (hazard ratio in the ICD group, 0.42; 95 percent confidence interval, 0.22 to 0.83; P=0.009). In contrast, there were 50 deaths from nonarrhythmic causes in the ICD group and 29 in the control group (hazard ratio in the ICD group, 1.75; 95 percent confidence interval, 1.11 to 2.76; P=0.02). CONCLUSIONS: Prophylactic ICD therapy does not reduce overall mortality in high-risk patients who have recently had a myocardial infarction. Although ICD therapy was associated with a reduction in the rate of death due to arrhythmia, that was offset by an increase in the rate of death from nonarrhythmic causes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite data linking decreased HRV with increased mortality, randomized trials in patients stratified for ICD implantation based on this parameter failed to demonstrate the usefulness of HRV in predicting benefit from ICD therapy (Hohnloser et al., 2004;Steinbeck et al., 2009).”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as Hohnloser et al., 2004
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
Kleiger, R. E., Miller, J. P., Bigger, J. T., & Moss, A. J. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90795-8 · Cited by 3,995
Rovere, M. T. L., Bigger, J. T., Marcus, F. I., Mortara, A., & Schwartz, P. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11144-8 · Cited by 3,120
The DAVID Trial Investigators* (2002) · JAMA · doi:10.1001/jama.288.24.3115 · Cited by 2,056
Connolly, S. J., Gent, M., Roberts, R. S., Dorian, P., Roy, D., Sheldon, R. S., Mitchell, L. B., Green, M. S., Klein, G. J., & O’Brien, B. (2000) · Circulation · doi:10.1161/01.cir.101.11.1297 · Cited by 1,607
Self-citationBigger, J. T., Fleiss, J. L., Kleiger, R., Miller, J. P., & Rolnitzky, L. M. (1984) · Circulation · doi:10.1161/01.cir.69.2.250 · Cited by 1,286
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials
Connolly, S. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2476 · Cited by 1,126
Self-citationBigger, J. T. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372201 · Cited by 1,020
Cairns, J. A., Connolly, S. J., Roberts, R., & Gent, M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)08171-8 · Cited by 957
Self-citationLa Rovere, M. T., Pinna, G. D., Hohnloser, S. H., Marcus, F. I., Mortara, A., Nohara, R., Bigger, J. T., Camm, A. J., & Schwartz, P. J. (2001) · Circulation · doi:10.1161/01.cir.103.16.2072 · Cited by 697
Self-citationClinical classification of cardiac deaths.
Hinkle, L. E., & Thaler, H. T. (1982) · Circulation · doi:10.1161/01.cir.65.3.457 · Cited by 638
Sudden cardiac death. Structure, function, and time-dependence of risk.
Myerburg, R. J., Kessler, K. M., & Castellanos, A. W. (1992) · PubMed · Cited by 484
Copie, X., Hnatkova, K., Staunton, A., Fei, L., Camm, A. J., & Malik, M. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00454-8 · Cited by 234
Time Dependence of Mortality Risk and Defibrillator Benefit After Myocardial Infarction
Wilber, D. J., Zareba, W., Hall, W. J., Brown, M. W., Lin, A. C., Andrews, M. L., Burke, M., & Moss, A. J. (2004) · Circulation · doi:10.1161/01.cir.0000121328.12536.07 · Cited by 232
Camm, A. J., Pratt, C. M., Schwartz, P. J., Al-Khalidi, H. R., Spyt, M. J., Holroyde, M. J., Karam, R., Sonnenblick, E. H., & Brum, J. M. G. (2004) · Circulation · doi:10.1161/01.cir.0000117090.01718.2a · Cited by 226
The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): Study protocol
Hohnloser, S. H., Connolly, S. J., Kück, K., Dorian, P., Fain, E. S., Hampton, J., Hatala, R., Pauly, A. C., Roberts, R. S., Themeles, E., et al. (2000) · American Heart Journal · doi:10.1067/mhj.2000.110088 · Cited by 69
Self-citationHohnloser, S. H., & Gersh, B. J. (2003) · Circulation · doi:10.1161/01.cir.0000054211.00668.9b · Cited by 26
Self-citation
Research works printed but not linked: 3
- Myerburg RJ, 1992, Circulation, 85, I
- Zuanetti G, 1999, Eur Heart J, 1, H52
- Mantel N, 1966, Cancer Chemother Rep, 50, 163
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
Self-citation
Metadata
- Authors
- Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J.
- Affiliations
- Goethe University Frankfurt (DE)
- St. Michael's Hospital (CA)
- University of Nottingham (GB)
- McMaster University (CA)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-12-09
- Volume
- 351
- Issue
- 24
- Pages
- 2481-2488
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2109205604
- Cited by
- 1,519
- References
- 22
- Citations by year
- 2026: 23 · 2025: 24 · 2024: 32 · 2023: 39 · 2022: 50 · 2021: 54 · 2020: 53 · 2019: 59 · 2018: 52 · 2017: 93 · 2016: 67 · 2015: 75 · 2014: 70 · 2013: 93 · 2012: 96
- FWCI
- 52.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- implantable cardioverter-defibrillator, acute myocardial infarction, all-cause mortality, left ventricular dysfunction, heart rate variability
- MeSH terms
- Adult, Aged, Arrhythmias, Cardiac, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Risk, Stroke Volume, Survival Analysis, Death, Sudden, Cardiac, Defibrillators, Implantable, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.